Genetically predicted type 2 diabetes mellitus mediates the causal association between plasma uric acid and ischemic stroke
- 17 May 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 134, 112267
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Serum Uric Acid Levels and Outcome of Acute Ischemic Stroke: a Dose–Response Meta-analysisMolecular Neurobiology, 2023
- Bacteria‐Derived Outer‐Membrane Vesicles Hitchhike Neutrophils to Enhance Ischemic Stroke TherapyAdvanced Materials, 2023
- Mendelian randomisation for mediation analysis: current methods and challenges for implementationEuropean Journal of Epidemiology, 2021
- Uric Acid Neuroprotection Associated to IL-6/STAT3 Signaling Pathway Activation in Rat Ischemic StrokeMolecular Neurobiology, 2020
- Mendelian Randomization Study of Obesity and Cerebrovascular DiseaseAnnals of Neurology, 2020
- Impact of glucose-lowering therapies on risk of stroke in type 2 diabetesDiabetes & Metabolism, 2017
- Interpreting findings from Mendelian randomization using the MR-Egger methodEuropean Journal of Epidemiology, 2017
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Serum Uric Acid Levels and the Risk of Type 2 Diabetes: A Prospective StudyThe American Journal of Medicine, 2010
- Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research DatabaseDiabetologia, 2006